Loading
eHealth, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 09 Mar 2026.
eHealth, Inc.: what insiders have been doing
eHealth, Inc. is a Healthcare & Pharma company. Its directors and officers file their transactions with SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 43 filings came from 10 insiders.
On the market, 2 insiders bought (2 purchases totalling €253k) while 1 insider sold (2 sales totalling €25k). On balance, insiders were net buyers of €228k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 finance chief and 1 chief executive. Biggest ticket of the year: €220k, bought by Duke Derrick A and made public on 2 March 2026.
In the case of 1 purchase, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last purchase on record was published on 9 March 2026, which is 223 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4.
With 43 filings in twelve months, the company is more active than the median of 19 filings across the 5,810 companies we follow on the same exchange. Since 2021, the database holds 19 purchases and 5 sales by insiders of the company. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 554.0 m USD and net income at 40.0 m USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
256
Thresholds
n/a
Buy Volume
€3M
19 ops. · all time
Sell Volume
€132,715
5 ops. · all time
Who traded when
BuySaleFRANCIS S. SOISTMAN Jr.2 sales
Derrick A. Duke1 buy
Gavin G. Galimi1 buy
John Joseph Dolan1 buy
Wolf Dale B1 sale
Since the insiders bought
- +3.7%Entry US$1.62 · Close at T+90 US$1.68
- +5.1%Entry US$1.56 · Close at T+90 US$1.64
- -62.1%Entry US$4.33 · Close at T+365 US$1.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,931 of 24,148 companies
51.9
score / 100
Value52
Quality52
FCF yld·
Earn yld-55%
EV/EBITDA1.8x
ROE2.9%
Gross mgn96%
Net mgn-1.9%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.70
Analyst consensus
4 analysts3.00/5
US$1.50Target US$1.81(+159%)US$2.00
Income statement
RevenueUS$554M
Gross profitUS$530.6M96% margin
EBITDAUS$83.2M15% margin
Net income-US$10.4M5.4% margin
Valuation
PER (forward)0.6x
P/Book0.0x
Beta1.63
Balance sheet & cash
Market capUS$22.4M
Total debtUS$134.4M
Free Cash Flow-US$40.7M
Debt / Equity14%
Profitability & ownership
ROE2.9%
ROA3.4%
% insiders7.6%
% institutions51.1%
Last declaration on 13 October 2026
Declarations256 total
842 shares@ US$0.70Common StockSEC:0001950061-26-000021:0
323 shares@ US$0.70Common StockSEC:0002005261-26-000023:0
465 shares@ US$0.70Common StockSEC:0001931967-26-000025:0
20,306 shares@ US$0.69130.062% mcap100.0% of flowCommonSEC144:0001950047-26-009994
20,306 shares@ US$0.69620.062% mcap0.4% of flowCommon StockSEC:0001233184-26-000019:0
20,306 shares@ US$0.69130.062% mcap0.4% of flowCommon StockSEC:0001233184-26-000019:1
20,306 shares@ US$0.69620.062% mcap25.4% of flowCommonSEC144:0001950047-26-009925
4,312 shares@ US$0.920.016% mcap1.7% of flowCommon StockSEC:0002005261-26-000021:0
5,859 shares@ US$0.920.022% mcap1.7% of flowCommon StockSEC:0001931967-26-000023:0
70,000 shares0Common StockSEC:0002005261-26-000019:0
70,000 shares0Common StockSEC:0001931967-26-000021:0
60,000 shares0Common StockSEC:0001950061-26-000019:0
37,296 shares@ US$1.13770.17% mcap100.0% of flowCommonSEC144:0001950047-26-008871
24,350 shares@ US$1.420.14% mcap12.0% of flowCommon StockSEC:0001499498-26-000006:0
465 shares@ US$1.620.0031% mcap0.2% of flowCommon StockSEC:0001931967-26-000019:0
841 shares@ US$1.620.0056% mcap0.3% of flowCommon StockSEC:0001950061-26-000017:0
323 shares@ US$1.620.0021% mcap0.2% of flowCommon StockSEC:0002005261-26-000017:0
61,041 sharesCommon StockSEC:0001509185-26-000002:0
61,041 sharesCommon StockSEC:0001793004-26-000008:0
61,041 sharesCommon StockSEC:0001786769-26-000009:0
4,311 sharesCommon StockSEC:0002005261-26-000015:0
3,588 shares@ US$1.890.013% mcap1.4% of flowCommon StockSEC:0001950061-26-000013:0
3,571 shares@ US$1.890.017% mcap2.8% of flowCommon StockSEC:0002005261-26-000013:0
4,206 shares@ US$1.890.015% mcap2.6% of flowCommon StockSEC:0001931967-26-000015:0
323 shares@ US$1.320.0011% mcap0.2% of flowCommon StockSEC:0002005261-26-000011:0
25 of 256 declarations
About eHealth, Inc.
eHealth, Inc. (Nasdaq: EHTH) is a U.S.-based online health insurance distribution platform. The company is headquartered in Austin, Texas, and was incorporated in Delaware in November 1997. It built one of the early digital marketplaces for health insurance in the United States, allowing consumers to research, compare, and enroll in coverage online. For French-speaking investors, the key point is that eHealth is listed on the Nasdaq market in the United States, so it trades as a U.S. healthcare services/platform name rather than as a traditional balance-sheet insurance carrier.
The company’s core business is health insurance brokerage and consumer guidance. Over time, eHealth has become particularly associated with Medicare, while still serving other insurance segments. Its main product lines include Medicare Advantage, Medicare Supplement, and Medicare Part D plans, as well as individual and family coverage, small-business plans, and selected ancillary products. The company positions itself as a carrier-agnostic marketplace, meaning it presents offerings from multiple insurance partners so consumers can evaluate options side by side. eHealth also emphasizes its digital platform, licensed benefit advisors, data integration, AI, analytics, and tools that support customer acquisition and enrollment.
Read moreShow less
From a competitive standpoint, eHealth operates in a crowded and heavily regulated market. Its performance is influenced by Medicare enrollment cycles, ACA-related activity, carrier pricing and plan design changes, and competition from other digital distribution channels, insurance agents, and government-sponsored platforms. The company’s strategic strengths are its brand recognition, long operating history, carrier relationships, omnichannel enrollment capabilities, and the ability to guide consumers through a complex purchasing process. Management has also highlighted efforts to build lifelong customer relationships, which suggests a more recurring, relationship-driven model than a one-off lead generation business.
Recent developments have been material. In January 2026, eHealth announced a new $125 million asset-based revolving credit facility to strengthen its capital structure and repay existing debt. In February 2026, the company unveiled a new growth strategy focused on trusted, lifelong customer relationships and on serving consumers across Medicare, ACA, and employer-sponsored ICHRA coverage needs. In May 2026, eHealth reported first-quarter 2026 results, following a 2024 that showed improved profitability and stronger Medicare-related volumes. The broader investment case therefore centers on execution in Medicare, the durability of its digital distribution model, and the company’s ability to manage leverage while expanding its platform-based healthcare insurance franchise in the United States.
